Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)Unusual Whales·20 hours agoDYN+1.05%
Biotech Stocks At 52-Week Highs - LH Rises With Genetic Testing Launch, DYN, SNDA, SLN, AMLX,rttnews·23 hours agoSLN-4.31%LH+4.34%
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | DYN Stock NewsStockTitan·Jul 24 at 07:05 AMDYN+1.05%
Dyne Therapeutics closes upsized public offering of 21,045,000 shares at $20.5 eachPUBT·Jul 23 at 03:29 PMDYN+1.05%EVR+0.11%
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional SharesUnusual Whales·Jul 23 at 03:08 PMDYN+1.05%
Dyne Therapeutics Upsized Equity Offering Strengthens Cash RunwayTip Ranks·Jul 22 at 04:51 PMDYN+1.05%
Dyne Therapeutics slides 3% in regular trading on earnings pressureUS Stock Market Update·Jul 22 at 01:50 PMDYN+1.05%
Dyne Therapeutics falls 7% during regular trading on earnings pressureUS Stock Market Update·Jul 22 at 11:11 AMDYN+1.05%
Biggest stock movers Wednesday: SMCI, DYN, GEV, T, and moreMSN·Jul 22 at 09:05 AMGEV-5.34%GOOGL+2.19%
Dyne Therapeutics falls 6% during regular trading on earnings concernsUS Stock Market Update·Jul 22 at 08:51 AMDYN+1.05%
Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Sessionbenzinga_article·Jul 22 at 08:19 AMCPHI+5.69%ADTN-5.16%